Evonik Venture Capital
Profile, fund size and portfolio
Evonik Venture Capital is the corporate venture arm of Evonik Industries, a chemicals and materials company. It was founded in 2012 and is based in Essen, Germany. It invests from seed to growth. Sectors it names: biotech and life sciences, climate and energy.
Every figure links to its source
Snapshot
Data behind this graphic
| Item | Value |
|---|---|
| Stage range | Seed to Growth |
| Sectors | Biotech and life sciences, Climate and energy |
| Geography | North America, Europe, Asia, Middle East and Africa |
| Offices | Essen, Germany, Hanau, Germany, Parsippany, United States, Shanghai, China |
Sources: S4 Evonik press release: Evonik more than doubles venture capital; S1 Evonik Venture Capital: overview.
Data behind this graphic
| Measure | Value | Unit | Kind | Source |
|---|---|---|---|---|
| Headline size | EUR 250M | AUM or capital under management | Stated by the firm or its parent | S4 |
| Companies backed | 25+ | companies | Stated by the firm | S4 |
| Companies on the firm's portfolio page | 30 | companies | Counted from the firm's own list | S2 |
Sources: S4 Evonik press release: Evonik more than doubles venture capital; S2 Evonik Venture Capital: our portfolio.
Where it invests and who leads it
Geography
- Headquarters
- Essen, Germany
- Offices
- Essen, Germany
- Hanau, Germany
- Parsippany, United States
- Shanghai, China
Investment regionsS4S1
LeadersS3
- Dr. Bernhard MohrManaging DirectorFind on LinkedInFirm page
- Dr. Jens BusseInvestment Director North EuropeFind on LinkedInFirm page
- Mark RedshawInvestment Director EuropeFind on LinkedInFirm page
- Erning CaoInvestment Director AsiaFind on LinkedInFirm page
- Lutz StoeberInvestment Director North AmericaFind on LinkedInFirm page
Key facts
| Fact | Value | Status | Source |
|---|---|---|---|
| Parent company | Evonik Industries | Single source | S4 |
| Parent industry | Chemicals and materials | Single source | S4 |
| Founded | 2012 | Single source | S4 |
| Headquarters | Essen, Germany | Single source | S4 |
| Status | Active | Single source | S1 |
| Capital source | Parent company only | Single source | S1 |
| Headline size | EUR 250M (AUM or capital under management) | Single source | S4 |
| Companies backed | 25+ | Single source | S4 |
| Stages | Seed, Series A, Series B, Growth (inferred from announced rounds) | Estimate | S4 |
Portfolio
The firm's portfolio page lists 30 companies.S2
The firm also states 25+ companies backed. The page list and the stated total measure different things.S4
Every company on the Evonik Venture Capital list
30 companies, as listed on the firm's own website.S2 Read the firm's list.
- Abolis
- Allay Therapeutics
- Azolla Ventures
- Biograil
- Capnamic
- Castor
- Circumfix Solutions
- Citrine Informatics
- Emerald Technology Ventures
- Global Brain
- GRC Sinogreen Fund
- Gründerfonds Ruhr
- High-Tech Gründerfonds
- Hosen Capital Fund
- HPNow
- Interface Polymers
- JLand Biotech
- Laxxon Medical
- Modern Meadow
- Numaferm
- Pangaea Ventures Fund
- Revivo BioSystems
- Richland Capital
- Smart AHC
- Strohm
- Tech Council Ventures II
- Union Labs
- Union Tech
- Velox
- Yttrium
Notable outcomes
IPOs and acquisitions of portfolio companies. Price shown only where published.
| Company | Type | Year | Acquirer or exchange | Source |
|---|---|---|---|---|
| Structured Polymers | Acquisition | 2019 | Evonik | S4 |
Official pages
Read the firm's own pages for current information.
Sources
- S1Evonik Venture Capital: overviewFirm
- S2Evonik Venture Capital: our portfolioFirm
- S3Evonik Venture Capital: teamFirm
- S4Evonik press release: Evonik more than doubles venture capitalParent company
- S5FundingWatcher corporate venture capital investor listThird-party report
Disclaimer and corrections
Not affiliated. This page is not affiliated with, endorsed by or sponsored by Evonik Venture Capital or any company named on it. Names and trademarks belong to their owners. Informational only. This is a public-source reference. It is not investment, legal or tax advice and not an offer or solicitation. Sources. Each figure names its source. Figures may have changed. Please read the firm's official pages, linked above. Corrections and takedown. To report an error or ask for a change or removal, use the correction form or email Richard@CorporateVentureCapital.com.
Spotted a mistake? Report a correction.